Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Primary idiopathic endocardial fibroelastosis in a four-month-old infant: Case report and brief literature review

Breadcrumb

  • Home
  • Primary idiopathic endocardial fibroelastosis in a four-month-old infant: Case report and brief literature review

Rikki Johnson 1, Muhammad Saleh 1, Rhea Pandit 1, Talina Fuentes 1, Andressa Balbi 2, Jessica Jahoda 3, 4 and Mohamed Aziz 4, * 

1 American University of the Caribbean, AUC, St. Maarten.
2 HCA Palms West Hospital, Florida, USA.
3 Memorial Healthcare System, Pembroke Pines, FL, USA.
4 Research Writing & Publication (RWP), LLC, NY, USA.

Case Report

World Journal of Biology Pharmacy and Health Sciences, 2026, 27(01), 106–111

Article DOI: 10.30574/wjbphs.2026.27.1.0391

DOI url: https://doi.org/10.30574/wjbphs.2026.27.1.0391

Received on 08 June 2026; revised on 13 July 2026; accepted on 16 July 2026

Primary idiopathic endocardial fibroelastosis (pEFE) is a rare infantile cardiomyopathy characterized by diffuse thickening of the ventricular endocardium by collagen and elastic tissue, leading to severe left ventricular dysfunction. This report describes a four-month-old male infant who presented with a three-week history of feeding difficulties, failure to thrive, and respiratory distress, which were initially misdiagnosed as gastroesophageal reflux. An acute episode of perioral cyanosis prompted emergency evaluation revealing profound left ventricular dilation and a severely reduced ejection fraction of 28%. Following the exclusion of anomalous left coronary artery from the pulmonary artery (ALCAPA) and other secondary causes via echocardiography and cardiac magnetic resonance imaging, an endomyocardial biopsy confirmed the diagnosis of pEFE. 
The infant was managed with intensive anti-heart failure pharmacotherapy, including captopril, carvedilol, furosemide, and spironolactone, alongside aggressive nutritional support. This medical regimen resulted in significant clinical improvement, with the ejection fraction recovering to 55% at the 18-month follow-up, despite persistent endocardial echogenicity. 
This case underscored the critical importance of maintaining a high index of suspicion for underlying cardiomyopathies in infants presenting with persistent feeding difficulties and respiratory symptoms, as early diagnosis and aggressive medical management can yield excellent long-term outcomes and reverse profound cardiac dysfunction in primary endocardial fibroelastosis (EFE).
 

Primary idiopathic endocardial fibroelastosis; Infantile cardiomyopathy; Collagen and elastic tissue; Left ventricular endocardial thickening; Heart failure

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0391.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Rikki Johnson, Muhammad Saleh, Rhea Pandit, Talina Fuentes, Andressa Balbi, Jessica Jahoda and Mohamed Aziz. Primary idiopathic endocardial fibroelastosis in a four-month-old infant: Case report and brief literature review. World Journal of Biology Pharmacy and Health Sciences, 2026, 27(01), 106–111. Article DOI: https://doi.org/10.30574/wjbphs.2026.27.1.0391

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution